Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever

Completed

• Conditions: Sickle Cell Anemia; Sickle Cell Thalassemia
• Interventions: Other: Observational

• Registration Number: NCT00736060
• Lead Sponsor: HaEmek Medical Center, Israel

Brief Summary

This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.

Detailed Description

The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment.

The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.

Study Timeline

• Study Start: 2008-05
• Study First Submitted: 2008-08-14
• Study First Submitted QC: 2008-08-14
• Study First Posted: 2008-08-15
• Study Completion: 2008-11
• Status Verified: 2011-08
• Last Update Submitted: 2011-08-25
• Last Update Posted: 2011-08-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

All patients admitted with fever as the only presenting symptom.

Exclusion Criteria

Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
1	Observational	Sickle cell anemia
2	Observational	Sickle cell thalassemia

Trial Locations

Locations (1)

Pediatric Hematology Unit - Ha'Emek Medical Center; 🇮🇱 Afula, Israel